Blogs about Biotechnology, Pharmaceutical and Healthcare

16:21 EDT 24th June 2016 | BioPortfolio

Read the latest opinions - blogs from pharmaceutical and life science industry experts.

Showing News Articles 1–25 of 60,000+

Friday 24th June 2016

Boston’s Newest Innovators and Influencers Meet at INFLUX: The Photos

We had a grand old time at this week’s blowout Boston event, Influx. Leaders from Akamai, MIT, Harvard, and other venerable institutions met with top folks from GE Ventures, IBM Watson Health, Dell-EMC, and startups and investors, to talk about boosting their businesses—and the region’s innovation profile—for the future. The Museum of Science was a […]

Sorry. Nasal spray flu vaccine doesn't work, says CDC panel

The “nasal spray” influenza vaccine, used by millions of Americans in recent years, should not be administered during the coming flu season, an advisory panel to the Centers for Disease Control and Prevention (CDC) has announced.The panel’s members — the Advisory Committee on Immunization Practices (ACIP) — came to that conclusion after reviewing all the latest scientific data regarding ...

The Pharmaceutical Perspective: How #Brexit and the Falling Sterling Impacts HCP FMV Rates and Policies in the UK

By Jacob Presson, Data Products Team Leader On June 23, 2016 the United Kingdom voted in a referendum to leave the European Union, to the surprise of most political observers. It must be noted the referendum does not have an immediate impact on the UK’s legal status as a member of the EU and negotiations […] The post The Pharmaceutical Perspective: How #Brexit and the Falling Sterling Impa...

Brexit Timebomb: Expect Effects On Drug Regulation, IP, Research And Trade

The UK's decision to leave the EU will have a wide range of effects on the life sciences sector, from drug approvals and clinical research to data exclusivity, patents and trade.

TGI Friday! Our weekly round-up of recently published research abstracts | 24 June 2016

This week - how much do physios know about hyper mobility syndrome? & the value of online forums to people with chronic conditions.

“Clinical development of ceftazidime-avibactam…Navigating an evolving regulatory environment”

David Melnick, M.D., Vice President Clinical Development, Anti-Infectives at Allergan Pharmaceuticals joined us for World Anti-Microbial Resistance Congress USA 2015 to discuss “navigating an evolving ... The post “Clinical development of ceftazidime-avibactam…Navigating an evolving regulatory environment” appeared first on Total Biopharma.

MannKind - Afrezza Scripts Still Slipping Ahead Of Re-Launch

MannKind Will Market Afrezza Better Than Sanofi Ever Did

When Sanofi announced it was returning the marketing rights for inhaled insulin Afrezza in January, doubts were cast on the future of MannKind Corp, the maker of the drug. Since then, the key question for MannKind’s shareholders is whether the company can build a salesforce that will do a better job selling Afrezza than Sanofi did. The person in charge of this effort is Michael Castagna, MannKin...

Evaluation of the Impact of National HIV Testing Day — United States, 2011–2014

For approximately 2 decades, June 27th has been designated as National human immunodeficiency virus (HIV) Testing Day (NHTD) to promote HIV testing and increase awareness of the importance of getting tested for HIV.

Healthcare Utilization and HIV Testing of Males Aged 15-39 in Physician Offices: 2009-2012

In 2006, CDC recommended routine HIV testing of adults and adolescents; however, testing coverage in the United States has been suboptimal. Among new HIV diagnoses in 2014, 81% were in males, with the highest number reported in those aged 20–29 years.

Directing Your Exit

Today you have an opportunity to direct your exit. You can write your life’s last act, but if you don’t a giant health care machine may give it an entirely different ending than you might prefer. You may not be the only actor on the stage. Given an opportunity the [...]

Bloomberg Philanthropies Provides $100M To Improve Health Information In 18 Countries

Eighteen countries will receive technical assistance and funding to develop new tools and systems to help gather more accurate information about the health of their citizens, Bloomberg Philanthropies announced this week. The group, which is funding Data for Health, a four-year, $100 million initiative aimed at improving health data in low- and middle-income nations, said it has the “potential...

Ogilvy CommonHealth Worldwide's Matt Giegerich Named Chairman of the Board for Charity Navigator

PARSIPPANY, NJ--(Marketwired - Jun 24, 2016) -  Ogilvy CommonHealth Worldwide (, the health behavior change specialists of Ogilvy & Mather (, Read more...

American Cannabis Company Announces a $5 Million Fixed Funding Commitment

DENVER, CO--(Marketwired - Jun 24, 2016) - American Cannabis Company, Inc. ( OTCQB : AMMJ) (the "Company"), a full-service business-to-business consulting solutions provider, and Read more...

Washington Post reporter on his move to the 'absolute worst place in America': a 'net positive' for family

Last August, Washington Post reporter Christopher Ingraham wrote an article identifying Red Lake County, Minnesota, as the “absolute worst place to live in the America.” Almost immediately, outraged locals (and both U.S. senators) inundated him with texts, tweets and emails, and even invited him to see the place for himself. He took them up on their offer — flying in for a tour, which he the...

Is Jakafi A Breakthrough For Incyte In Blood Cancers?

EC Releases Endocrine-Disruptor Criteria, Drawing Heavily On WHO Definitions

The European Commission’s newly released criteria for identifying endocrine disruptors in the plant-protection and biocidal product sectors have no direct regulatory impact on cosmetics, but could signal the approach the EC will take in other areas as it works to manage endocrine-disruptor risks. A review of the Cosmetics Regulation’s applicability to endocrine disruptors is nearing completion...

'Smartphone Blindness,' And Other Health Hazards Of Our Favorite Gadgets

From your eyes to your neck to your mental health, smartphones can pose some risks.

It’s time to change the way we choose medical students

The USA trains its physicians differently from every other Western country I know. Everyone (with rare exceptions) who goes to medical school first must get a four-year undergraduate college degree in something. There are no such degrees in medicine, although the overwhelming majority of students going on to medical school major in one of the sciences, […]

Independence Blue Cross first insurer in Pennsylvania to cover bronchial thermoplasty, an ...

PHILADELPHIA, June 24, 2016 (GLOBE NEWSWIRE)

Arizona Heat Becomes Dangerous for Low-Income Persons With Disabilities

GLENDALE, AZ--(Marketwired - June 24, 2016) -Bobby Eddington lives in a modest studio apartment with his two small dogs. The summer heat has Read more...

Medtronic Marks 39th Consecutive Year of Dividend Increases

Click to view a price quote on MDT. Click to research the Health Services industry.

More than Brexit Moving Stocks as Russell Rebalances

WOWI, Inc. Is Now the Driving Force of Jolen, Inc. With Its New Strategy and Name

CENTENNIAL, CO--(Marketwired - Jun 24, 2016) -  WOWI, Inc. ( OTC PINK : WOWU) is pleased to announce its growth strategy in the U.S. Read more...

Why evidence is key in cancer care

There is nothing like first-hand evidence. This statement from Sherlock Holmes takes on a whole new meaning when applied to cancer care. Evidence-based care has a dramatic impact in improving outcomes for patients. For a policymaker or a doctor, much like a detective, following a trail of evidence is paramount to drilling down to finding solutions. Three key steps are to be followed:  Gathering ...

Quick Search